resveratrol has been researched along with Cancer of Ovary in 58 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (20.69) | 29.6817 |
| 2010's | 34 (58.62) | 24.3611 |
| 2020's | 12 (20.69) | 2.80 |
| Authors | Studies |
|---|---|
| Maitinuri, A; Muhanmode, Y; Shen, G; Wen, MK | 1 |
| Beyer, S; Burges, A; Chen, F; Czogalla, B; Hester, A; Jeschke, U; Kolben, T; Kolben, TM; Mahner, S; Mayerhofer, A; Mayr, D; Meister, S; Schmoeckel, E; Trillsch, F | 1 |
| Czajkowski, M; Józkowiak, M; Nowicki, A; Pawlak, M; Piotrowska-Kempisty, H; Rolle, K; Skupin-Mrugalska, P; Wawrzyniak, D; Wierzchowski, M | 1 |
| Chen, J; Chen, JG; He, JH; He, SY; Huang, ST; Huang, ZH; Lin, WM; Ye, HY | 1 |
| Bidgoli, SA; Chaichian, S; Moazzami, B; Nikfar, B | 1 |
| Gor, R; Ramachandran, I; Ramalingam, S | 1 |
| Dhanasekaran, DN; Ferraresi, A; Garavaglia, B; Ha, JH; Isidoro, C; Salwa, A; Seca, C; Vallino, L; Vidoni, C | 1 |
| Borkowska, A; Brodaczewska, K; Filipiak-Duliban, A; Gawrylak, A; Kieda, C; Kominek, A; Kubiak, JZ; Lewicki, S; Majewska, A; Piwocka, K; Siewiera, J; Synowiec, A; Szczylik, C; Szenajch, J; Waś, H; Wcisło, G; Wilkus, K | 1 |
| Alharbi, SA; Ali Al-Kahtani, M; El-Kott, AF; Shati, AA | 1 |
| Guo, X; Mei, J; Zhang, C | 1 |
| Jodynis-Liebert, J; Jozkowiak, M; Krajka-Kuzniak, V; Nowicki, A; Piotrowska-Kempisty, H; Ramlau, P; Rucinski, M; Skupin-Mrugalska, P; Wierzchowski, M | 1 |
| Guo, L; Long, Q; Pu, L; Zhu, W | 1 |
| Gao, M; Wang, W; Wang, Z; Wei, B; Yao, S; Zhan, L | 1 |
| Bellina, F; De Domenico, S; Del Mercato, LL; Giudetti, AM; Guazzelli, N; Lessi, M; Maffia, M; Manzini, C; Santino, A; Simeone, P; Stanca, E; Tinelli, A; Vergara, D | 1 |
| Castiglioni, A; Chiorino, G; Dhanasekaran, DN; Ferraresi, A; Follo, C; Isidoro, C; Titone, R | 1 |
| Gurunathan, S; Peng, QL; Yuan, YG | 1 |
| Lin, LZ; Liu, J; Nie, JH; Zhong, LX | 1 |
| Chen, G; Li, X; Liu, Y; Luo, Y; Tong, L; Wang, Y | 1 |
| Kim, TH; Park, JH; Woo, JS | 1 |
| Alani, AWG; Cote, B; Fatease, AA; LeBlanc, N; Nguyen, DX; Rao, DA; Shah, V | 1 |
| Chen, CE; Cheng, GY; Chiang, HL; Crawford, DR; Delmas, D; Hsieh, TC; Hwang, J; Lin, HY; Lin, S; Liu, LF; Tang, HY; Vang, O; Whang-Peng, J; Wu, JM | 1 |
| Choi, DW; Choi, KC; Hwang, KA; Kang, NH; Lee, HR | 1 |
| Asselin, É; Baribeau, S; Chaudhry, P; Parent, S | 1 |
| Alani, AW; Carlson, LJ; Cote, B; Rao, DA | 1 |
| Książek, K; Mikuła-Pietrasik, J; Sosińska, P | 1 |
| Gwak, H; Haegeman, G; Song, YS; Tsang, BK | 1 |
| Arzuman, L; Beale, P; Huq, F; Proschogo, N; Yu, JQ | 1 |
| Kitanaka, C; Kurachi, H; Ohta, T; Okada, M; Seino, M; Seino, S; Shibuya, K; Suzuki, S; Takeda, H | 1 |
| Chen, XY; Li, H; Liu, J; Liu, XY; Wu, ML; Zhang, Y; Zhong, LX; Zhong, MJ | 1 |
| Fang, Z; Hao, E; Lang, F; Li, F; Qin, Z; Zhang, H | 1 |
| Brewińska-Olchowik, M; Książek, K; Mikuła-Pietrasik, J; Murias, M; Piwocka, K; Sosińska, P; Szpurek, D; Wierzchowski, M | 1 |
| Cho, KH; Hur, GM; Jeong, BY; Kim, SH; Kim, YN; Lee, HY; Park, CG | 1 |
| Gossner, G; He, G; Kueck, AS; Kuick, RD; Liu, JR; Opipari, AW; Tan, L; Wahl, H; Wang, W | 1 |
| Dhanasekaran, DN; Gwak, H; Kim, S; Song, YS | 1 |
| Borys, S; Jodynis-Liebert, J; Kaczmarek, M; Kucińska, M; Murias, M; Piotrowska-Kempisty, H; Ruciński, M; Wierzchowski, M; Zawierucha, P; Łażewski, D | 1 |
| Alabiso, O; Chiorino, G; Ferraresi, A; Galetto, A; Isidoro, C; Morani, F; Phadngam, S | 1 |
| Chitcholtan, K; Garrill, A; Sykes, PH; Tino, AB | 1 |
| Abd Elmageed, ZY; Azam, GA; Braley, P; Fathi, IM; Gaur, RL; Nguyen, L; Ouhtit, A; Raj, MH; Rao, PN; Zhou, J | 1 |
| Cao, L; Chen, W; Deng, CX; Finkel, T; Gardner, K; Hung, MC; Kim, HS; Lee, MH; Luhasen, T; Man, YG; Vassilopoulos, A; Wang, RH; Xiao, C; Xu, X; Zheng, Y | 1 |
| Choi, BY; Kundu, JK; Lee, MH; Na, HK; Shin, YK; Surh, YJ | 1 |
| Hoekstra, A; Rodriguez, GC | 1 |
| Gu, A; Guo, L; Peng, Y; Sui, L; Wang, J; Yao, J | 1 |
| Chen, J; Guo, LY; Li, YL; Peng, Y; Sui, LH; Wang, J; Yao, JP; Zhang, GM | 1 |
| Crawford, DR; Davis, PJ; Hwang, J; Lin, C; Lin, HY; Lin, S; Meng, R; Sebuyira, A; Tang, HY; Westfall, JE; Yu, PY | 1 |
| Björklund, M; Gogvadze, V; Roos, J; Shoshan, M | 1 |
| Beale, P; Chan, C; Huq, F; Nessa, MU; Yu, JQ | 1 |
| Alberti, S; De Domenico, S; Del Boccio, P; Leporatti, S; Maffia, M; Pieragostino, D; Salzet, M; Santino, A; Simeone, P; Tinelli, A; Toraldo, D; Urbani, A; Vergara, D; Vergaro, V | 1 |
| Choi, KC; Hwang, KA; Hyun, SH; Jeung, EB; Kang, NH; Kim, TH | 1 |
| Bishayee, A; Blanco, D; Booth, TD; Marcanthony, S; Sloan, T; Stakleff, KS | 1 |
| Cho, KH; Jeong, KJ; Kang, J; Kim, H; Lee, HY; Mills, GB; Panupinthu, N; Park, CG | 1 |
| An, SW; Cho, HS; Choi, YH; Chung, HC; Kim, JS; Kim, MS; Kim, YH; Lee, SW; Oh, TJ; Rha, SY; Woo, SK; Yang, SH | 1 |
| Aurora, A; Boitano, AE; Liu, JR; Opipari, AW; Sorenson, DR; Tan, L | 1 |
| Cao, Z; Fang, J; Jiang, BH; Shi, X; Xia, C | 1 |
| Agarwal, C; Agarwal, R; Sclafani, RA; Singh, RP; Siriwardana, S; Tyagi, A | 1 |
| Balulad, SS; Bennett, JA; Keller, RS; Rezk, YA | 1 |
| He, TP; Li, K; Liang, NC; Mo, LE; Qin, YM | 1 |
| Choi, M; Griffith, KA; Huang, J; Kueck, A; Liu, JR; Opipari, AW; Tan, L; Wahl, H | 1 |
| Choi, WS; Han, JW; Jeong, KJ; Kim, BK; Kim, YK; Kim, YM; Lee, HY; Lee, J; Park, SY; Yoon, DS | 1 |
1 review(s) available for resveratrol and Cancer of Ovary
| Article | Year |
|---|---|
LncRNAs and MiRNAs: New Targets for Resveratrol in Ovarian Cancer Research.
Topics: Carcinogenesis; Female; Humans; MicroRNAs; Ovarian Neoplasms; Resveratrol; RNA, Long Noncoding | 2023 |
57 other study(ies) available for resveratrol and Cancer of Ovary
| Article | Year |
|---|---|
Curcumin and resveratrol inhibit chemoresistance in cisplatin-resistant epithelial ovarian cancer cells via targeting P13K pathway.
Topics: Curcumin; Drug Resistance, Neoplasm; Female; Humans; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Resveratrol | 2021 |
The role of resveratrol, Sirtuin1 and RXRα as prognostic markers in ovarian cancer.
Topics: Cell Line, Tumor; Female; Humans; Ovarian Neoplasms; Prognosis; Resveratrol; Retinoid X Receptor alpha; Sirtuin 1 | 2022 |
Enhanced biological activity of liposomal methylated resveratrol analog 3'-hydroxy-3,4,5,4'-tetramethoxystilbene (DMU-214) in 3D patient-derived ovarian cancer model.
Topics: Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Female; Humans; Liposomes; Ovarian Neoplasms; Resveratrol; Stilbenes | 2022 |
Resveratrol reduces lactate production and modifies the ovarian cancer immune microenvironment.
Topics: Carcinoma, Ovarian Epithelial; Female; Humans; Immune Checkpoint Inhibitors; Lactic Acid; Neoplasms; Ovarian Neoplasms; Polyphenols; Programmed Cell Death 1 Receptor; Resveratrol; Tumor Microenvironment | 2022 |
Targeting the Cancer Stem Cells in Endocrine Cancers with Phytochemicals.
Topics: Female; Genistein; Humans; Neoplastic Stem Cells; Ovarian Neoplasms; Phytochemicals; Resveratrol | 2022 |
Glycolysis Inhibition of Autophagy Drives Malignancy in Ovarian Cancer: Exacerbation by IL-6 and Attenuation by Resveratrol.
Topics: Autophagy; Cell Line, Tumor; Female; Glycolysis; Humans; Interleukin-6; Ovarian Neoplasms; Resveratrol | 2023 |
Hypoxia, but Not Normoxia, Reduces Effects of Resveratrol on Cisplatin Treatment in A2780 Ovarian Cancer Cells: A Challenge for Resveratrol Use in Anticancer Adjuvant Cisplatin Therapy.
Topics: Cell Hypoxia; Cell Line, Tumor; Cisplatin; Female; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Ovarian Neoplasms; Resveratrol; Tumor Microenvironment; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2023 |
The apoptotic effect of resveratrol in ovarian cancer cells is associated with downregulation of galectin-3 and stimulating miR-424-3p transcription.
Topics: Caspase 3; Cell Movement; Cell Proliferation; Down-Regulation; Female; Galectin 3; Humans; MicroRNAs; Ovarian Neoplasms; Proto-Oncogene Proteins c-bcl-2; Resveratrol | 2019 |
Development of Drug Dual-Carriers Delivery System with Mitochondria-Targeted and pH/Heat Responsive Capacity for Synergistic Photothermal-Chemotherapy of Ovarian Cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Drug Liberation; Female; Ferritins; Graphite; Hot Temperature; Humans; Hydrogen-Ion Concentration; Indoles; Infrared Rays; Mice, Nude; Mitochondria; Nanostructures; Ovarian Neoplasms; Resveratrol; Xenograft Model Antitumor Assays | 2020 |
The Effect of 3'-Hydroxy-3,4,5,4'-Tetramethoxy -stilbene, the Metabolite of the Resveratrol Analogue DMU-212, on the Motility and Proliferation of Ovarian Cancer Cells.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Humans; Kruppel-Like Factor 4; Ovarian Neoplasms; Resveratrol; Stilbenes; Transcriptome | 2020 |
RGD-Conjugated Resveratrol HSA Nanoparticles as a Novel Delivery System in Ovarian Cancer Therapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms, Experimental; Oligopeptides; Ovarian Neoplasms; Resveratrol; Serum Albumin, Human | 2020 |
Upregulation of MicroRNA-34a Sensitizes Ovarian Cancer Cells to Resveratrol by Targeting Bcl-2.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Ovarian Neoplasms; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Up-Regulation | 2021 |
Anticancer effects of novel resveratrol analogues on human ovarian cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Movement; Epidermal Growth Factor; Epithelial-Mesenchymal Transition; Female; Humans; Interleukin-6; Ovarian Neoplasms; Resveratrol; Signal Transduction; Stilbenes | 2017 |
The protein restriction mimetic Resveratrol is an autophagy inducer stronger than amino acid starvation in ovarian cancer cells.
Topics: Amino Acids; Antineoplastic Agents, Phytogenic; Autophagy; Blotting, Western; Cell Line, Tumor; Cluster Analysis; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Microscopy, Fluorescence; Ovarian Neoplasms; Resveratrol; Signal Transduction; Stilbenes | 2017 |
Silver nanoparticles enhance the apoptotic potential of gemcitabine in human ovarian cancer cells: combination therapy for effective cancer treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Drug Delivery Systems; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Metal Nanoparticles; Ovarian Neoplasms; Resveratrol; Silver; Stilbenes | 2017 |
Correlation of ARHI upregulation with growth suppression and STAT3 inactivation in resveratrol-treated ovarian cancer cells.
Topics: Antioxidants; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Ovarian Neoplasms; Resveratrol; rho GTP-Binding Proteins; STAT3 Transcription Factor; Stilbenes; Up-Regulation | 2018 |
Resveratrol inhibits the proliferation and induces the apoptosis in ovarian cancer cells via inhibiting glycolysis and targeting AMPK/mTOR signaling pathway.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Protein Kinases; Proto-Oncogene Proteins c-akt; Resveratrol; TOR Serine-Threonine Kinases; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |
Resveratrol induces cell death through ROS‑dependent downregulation of Notch1/PTEN/Akt signaling in ovarian cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspases; Cell Death; Cell Line, Tumor; Cell Survival; Female; Gene Expression Regulation, Neoplastic; Humans; Ovarian Neoplasms; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Reactive Oxygen Species; Receptor, Notch1; Resveratrol; Signal Transduction | 2019 |
Chemosensitization and mitigation of Adriamycin-induced cardiotoxicity using combinational polymeric micelles for co-delivery of quercetin/resveratrol and resveratrol/curcumin in ovarian cancer.
Topics: Animals; Apoptosis; Cardiotoxicity; Cell Line, Tumor; Cell Survival; Curcumin; Doxorubicin; Drug Delivery Systems; Female; Humans; Inhibitory Concentration 50; Luminescent Measurements; Mice; Micelles; Ovarian Neoplasms; Polymers; Quercetin; Resveratrol; Stroke Volume; Troponin I; Xenograft Model Antitumor Assays | 2019 |
Mechanisms of ceramide-induced COX-2-dependent apoptosis in human ovarian cancer OVCAR-3 cells partially overlapped with resveratrol.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Caspase 3; Caspase 7; Cell Line, Tumor; Ceramides; Cyclooxygenase 2; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Nitrobenzenes; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Resveratrol; RNA, Small Interfering; Stilbenes; Sulfonamides; Tumor Suppressor Protein p53 | 2013 |
Resveratrol regulates the cell viability promoted by 17β-estradiol or bisphenol A via down-regulation of the cross-talk between estrogen receptor α and insulin growth factor-1 receptor in BG-1 ovarian cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Benzhydryl Compounds; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Down-Regulation; Estradiol; Estrogen Receptor alpha; Estrogens, Non-Steroidal; Female; Gene Expression Regulation, Neoplastic; Humans; Insulin Receptor Substrate Proteins; Neoplasm Proteins; Ovarian Neoplasms; Phenols; Phosphorylation; Phytoestrogens; Protein Processing, Post-Translational; Receptor, IGF Type 1; Resveratrol; Signal Transduction; Stilbenes | 2013 |
Resveratrol inhibits cisplatin-induced epithelial-to-mesenchymal transition in ovarian cancer cell lines.
Topics: Analysis of Variance; Blotting, Western; Cell Death; Cell Line, Tumor; Cisplatin; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation; Humans; Ovarian Neoplasms; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Snail Family Transcription Factors; Stilbenes; Transcription Factors | 2014 |
Polymeric micellar co-delivery of resveratrol and curcumin to mitigate in vitro doxorubicin-induced cardiotoxicity.
Topics: Antineoplastic Agents; Apoptosis; Cardiotoxicity; Cell Line; Cell Line, Tumor; Cell Survival; Curcumin; Doxorubicin; Drug Carriers; Drug Combinations; Female; Humans; Micelles; Myocytes, Cardiac; Ovarian Neoplasms; Poloxamer; Resveratrol; Stilbenes | 2014 |
Resveratrol inhibits ovarian cancer cell adhesion to peritoneal mesothelium in vitro by modulating the production of α5β1 integrins and hyaluronic acid.
Topics: Antineoplastic Agents, Phytogenic; Cell Adhesion; Epithelial Cells; Epithelium; Female; Humans; Hyaluronic Acid; Integrin alpha5beta1; Ovarian Neoplasms; Peritoneum; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2014 |
Cancer-specific interruption of glucose metabolism by resveratrol is mediated through inhibition of Akt/GLUT1 axis in ovarian cancer cells.
Topics: Apoptosis; Cell Line; Cell Line, Tumor; Cell Membrane; Epithelial Cells; Female; Glucose; Glucose Transporter Type 1; Humans; Ovarian Neoplasms; Protein Transport; Proto-Oncogene Proteins c-akt; Resveratrol; RNA, Messenger; Signal Transduction; Stilbenes; Tumor Suppressor Protein p53 | 2015 |
Synthesis of a monofunctional platinum compound and its activity alone and in combination with phytochemicals in ovarian tumor models.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; Cisplatin; Curcumin; Deoxyribonuclease BamHI; DNA; DNA Fragmentation; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Drug Synergism; Female; Genistein; Glutathione; Humans; Organoplatinum Compounds; Ovarian Neoplasms; Phytochemicals; Plasmids; Platinum Compounds; Resveratrol; Stilbenes | 2014 |
Differential contribution of ROS to resveratrol-induced cell death and loss of self-renewal capacity of ovarian cancer stem cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Female; Humans; Neoplastic Stem Cells; Ovarian Neoplasms; Oxidative Stress; Reactive Oxygen Species; Resveratrol; Stilbenes | 2015 |
Inhibition of STAT3 signaling as critical molecular event in resveratrol-suppressed ovarian cancer cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Gene Expression Regulation, Neoplastic; Humans; Ovarian Neoplasms; Phosphorylation; Receptors, Notch; Resveratrol; STAT3 Transcription Factor; Stilbenes; Wnt Signaling Pathway | 2015 |
Apoptotic Cell Death Induced by Resveratrol Is Partially Mediated by the Autophagy Pathway in Human Ovarian Cancer Cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Autophagy-Related Protein 5; Caspase 3; Cell Line, Tumor; Chloroquine; Female; Humans; Membrane Potential, Mitochondrial; Microtubule-Associated Proteins; Ovarian Neoplasms; Oxidative Stress; Reactive Oxygen Species; Resveratrol; RNA Interference; RNA, Small Interfering; Stilbenes | 2015 |
High Potency of a Novel Resveratrol Derivative, 3,3',4,4'-Tetrahydroxy-trans-stilbene, against Ovarian Cancer Is Associated with an Oxidative Stress-Mediated Imbalance between DNA Damage Accumulation and Repair.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Apoptosis; Caspase 3; Caspase 8; Caspase 9; Catalase; Catechols; Cell Line, Tumor; Cell Proliferation; Deoxyguanosine; DNA Damage; DNA Glycosylases; DNA Repair; Female; Humans; Ovarian Neoplasms; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Reactive Oxygen Species; Resveratrol; Stilbenes; Superoxide Dismutase | 2015 |
Resveratrol attenuates norepinephrine-induced ovarian cancer invasiveness through downregulating hTERT expression.
Topics: Adrenergic beta-Antagonists; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Down-Regulation; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Neoplasm Invasiveness; Norepinephrine; Ovarian Neoplasms; Phosphorylation; Resveratrol; Signal Transduction; Snail Family Transcription Factors; src-Family Kinases; Stilbenes; Telomerase; Transfection | 2016 |
Resveratrol inhibits ovarian tumor growth in an in vivo mouse model.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Carcinoma, Ovarian Epithelial; Cell Proliferation; Cell Survival; Cisplatin; Female; Glucose; Glycolysis; Humans; In Vitro Techniques; Mice; Neoplasm Transplantation; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Resveratrol; Stilbenes; Xenograft Model Antitumor Assays | 2016 |
Resveratrol triggers ER stress-mediated apoptosis by disrupting N-linked glycosylation of proteins in ovarian cancer cells.
Topics: Activating Transcription Factor 6; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; eIF-2 Kinase; Endoplasmic Reticulum Stress; Enzyme Activation; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Glycosylation; Humans; Neoplasm Proteins; Oncogene Proteins; Ovarian Neoplasms; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Pyrophosphatases; Resveratrol; Signal Transduction; Stilbenes; Time Factors; Transcription Factor CHOP; Transfection | 2016 |
3'-hydroxy-3,4,5,4'-tetramethoxystilbene, the metabolite of resveratrol analogue DMU-212, inhibits ovarian cancer cell growth in vitro and in a mice xenograft model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Genome, Human; Humans; Metabolome; Mice; Mice, SCID; Oligonucleotide Array Sequence Analysis; Ovarian Neoplasms; Real-Time Polymerase Chain Reaction; Resveratrol; Signal Transduction; Stilbenes; Tumor Burden; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2016 |
Resveratrol inhibits IL-6-induced ovarian cancer cell migration through epigenetic up-regulation of autophagy.
Topics: Autophagy; Beclin-1; Cell Line, Tumor; Cell Movement; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Interleukin-6; Ovarian Neoplasms; Resveratrol; rho GTP-Binding Proteins; Stilbenes; Up-Regulation | 2017 |
Resveratrol and acetyl-resveratrol modulate activity of VEGF and IL-8 in ovarian cancer cell aggregates via attenuation of the NF-κB protein.
Topics: Cell Aggregation; Cell Line, Tumor; Cell Proliferation; Energy Metabolism; Female; Humans; Interleukin-8; NF-kappa B; Ovarian Neoplasms; Resveratrol; Signal Transduction; Spheroids, Cellular; Stilbenes; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2016 |
Synergistic action of dietary phyto-antioxidants on survival and proliferation of ovarian cancer cells.
Topics: Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis Regulatory Proteins; Cell Cycle; Drug Synergism; Female; Humans; Indoles; Nitric Oxide; Ovarian Neoplasms; Oxazines; Resveratrol; Staining and Labeling; Stilbenes; Xanthenes | 2008 |
Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis.
Topics: Animals; Antineoplastic Agents, Phytogenic; BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; Epigenesis, Genetic; Female; Genes, BRCA1; Germ-Line Mutation; Humans; Inhibitor of Apoptosis Proteins; Mammary Neoplasms, Experimental; Mice; Mice, Mutant Strains; Mice, Nude; Mice, Transgenic; Microtubule-Associated Proteins; Neoplasm Proteins; Ovarian Neoplasms; Repressor Proteins; Resveratrol; RNA Interference; Sirtuin 1; Sirtuins; Stilbenes; Survivin | 2008 |
Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: eukaryotic elongation factor 1A2 as a potential target.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Growth Processes; Down-Regulation; Female; Humans; Insulin; Mice; Mice, Inbred BALB C; NIH 3T3 Cells; Ovarian Neoplasms; Peptide Elongation Factor 1; Proto-Oncogene Proteins c-akt; Resveratrol; Stilbenes; Xenograft Model Antitumor Assays | 2009 |
Chemoprevention of ovarian cancer.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Apoptosis; Carcinoma; Chemoprevention; Chickens; Disease Models, Animal; Drug Delivery Systems; Fatty Acids, Omega-3; Female; Humans; Mice; Neoplasm Proteins; Ovarian Neoplasms; Phytoestrogens; Progestins; Resveratrol; Retinoids; Stilbenes; Vitamin D | 2009 |
Anticancer activity and molecular mechanism of resveratrol-bovine serum albumin nanoparticles on subcutaneously implanted human primary ovarian carcinoma cells in nude mice.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Caspase 3; Caspase 9; Cattle; Chromatography, High Pressure Liquid; Cytochromes c; Female; Humans; In Situ Nick-End Labeling; Injections, Subcutaneous; Mice; Mice, Nude; Mitochondria; Nanoparticles; Ovarian Neoplasms; Resveratrol; Serum Albumin, Bovine; Signal Transduction; Stilbenes; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2010 |
[Mechanisms of resveratrol bovine serum albumin nanoparticle-induced cell death in human ovarian cancer SKOV3 cells].
Topics: Apoptosis; Caspase 3; Caspase 9; Cell Death; Cell Line, Tumor; Cytochromes c; Female; Humans; Nanoparticles; Ovarian Neoplasms; Resveratrol; Stilbenes | 2010 |
Inducible COX-2-dependent apoptosis in human ovarian cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Chromatin Immunoprecipitation; Cyclooxygenase 2; Female; Humans; Microscopy, Confocal; Mitogen-Activated Protein Kinases; Ovarian Neoplasms; Protein Transport; Resveratrol; RNA, Small Interfering; Signal Transduction; Stilbenes; SUMO-1 Protein; Transfection; Tumor Suppressor Protein p53 | 2011 |
Resveratrol induces SIRT1- and energy-stress-independent inhibition of tumor cell regrowth after low-dose platinum treatment.
Topics: Antineoplastic Agents; Carboplatin; Cell Cycle; Cell Death; Cell Line, Tumor; Cisplatin; Female; Humans; Ovarian Neoplasms; PTEN Phosphohydrolase; Resveratrol; Sirtuin 1; Stilbenes; Stress, Physiological | 2011 |
Combinations of resveratrol, cisplatin and oxaliplatin applied to human ovarian cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cisplatin; DNA Adducts; Drug Synergism; Female; Humans; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Resveratrol; Stilbenes | 2012 |
Resveratrol downregulates Akt/GSK and ERK signalling pathways in OVCAR-3 ovarian cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Microscopy, Confocal; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Phosphorylation; Proteomics; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Stilbenes | 2012 |
Induced growth of BG-1 ovarian cancer cells by 17β-estradiol or various endocrine disrupting chemicals was reversed by resveratrol via downregulation of cell cycle progression.
Topics: Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Endocrine Disruptors; Estradiol; Female; Humans; Ovarian Neoplasms; Resveratrol; Stilbenes | 2012 |
Resveratrol exerts differential effects in vitro and in vivo against ovarian cancer cells.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Lung Neoplasms; Ovarian Neoplasms; Rats; Rats, Inbred F344; Resveratrol; Stilbenes | 2012 |
EGFR mediates LPA-induced proteolytic enzyme expression and ovarian cancer invasion: inhibition by resveratrol.
Topics: Cell Line, Tumor; ErbB Receptors; Female; Humans; Immunoblotting; Immunoprecipitation; Lysophospholipids; Ovarian Neoplasms; Phosphorylation; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Stilbenes | 2013 |
Genome-scale analysis of resveratrol-induced gene expression profile in human ovarian cancer cells using a cDNA microarray.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Nucleus; DNA, Complementary; Female; Gene Expression Regulation, Neoplastic; Genome; Humans; NAD(P)H Dehydrogenase (Quinone); Oligonucleotide Array Sequence Analysis; Ovarian Neoplasms; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA; Stilbenes; Time Factors; Tumor Suppressor Protein p53; Up-Regulation | 2003 |
Resveratrol-induced autophagocytosis in ovarian cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Cell Cycle; Cell Line, Tumor; Cell Survival; Cisplatin; Female; Humans; Kinetics; Microscopy, Fluorescence; Ovarian Neoplasms; Plasmids; Resveratrol; Stilbenes | 2004 |
trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents, Phytogenic; Blotting, Northern; Blotting, Western; Carrier Proteins; Cell Cycle Proteins; Cell Line, Tumor; Dose-Response Relationship, Drug; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Eukaryotic Initiation Factor-4E; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Luciferases; MAP Kinase Signaling System; Neovascularization, Pathologic; Ovarian Neoplasms; Phosphoproteins; Proteasome Endopeptidase Complex; Protein Biosynthesis; Resveratrol; Ribosomal Protein S6 Kinases; RNA, Messenger; Stilbenes; Time Factors; Transcription Factors; Transfection; Vascular Endothelial Growth Factor A | 2004 |
Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells.
Topics: Antineoplastic Agents, Phytogenic; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; CDC2 Protein Kinase; cdc25 Phosphatases; Cell Cycle Proteins; Checkpoint Kinase 1; Checkpoint Kinase 2; DNA-Binding Proteins; Female; Humans; Ovarian Neoplasms; Phosphorylation; Protein Kinases; Protein Serine-Threonine Kinases; Resveratrol; Ribonucleotide Reductases; S Phase; Signal Transduction; Stilbenes; Tumor Cells, Cultured; Tumor Suppressor Proteins; Tyrosine | 2005 |
Use of resveratrol to improve the effectiveness of cisplatin and doxorubicin: study in human gynecologic cancer cell lines and in rodent heart.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bradycardia; Cardiotonic Agents; Cell Division; Cell Survival; Cells, Cultured; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Female; Humans; Long QT Syndrome; Mice; Myocytes, Cardiac; Ovarian Neoplasms; Rats; Resveratrol; Stilbenes; Uterine Neoplasms | 2006 |
[Study on the effect of resveratrol on metastasis-associated ability of ovarian carcinoma HO-8910PM cells in vitro].
Topics: Antineoplastic Agents, Phytogenic; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drugs, Chinese Herbal; Female; Flow Cytometry; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Ovarian Neoplasms; Plants, Medicinal; Resveratrol; Stilbenes | 2007 |
Resveratrol inhibits glucose metabolism in human ovarian cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Autophagy; Caspases; Cell Growth Processes; Cell Line, Tumor; Deoxyglucose; Female; Glucose; Humans; Ovarian Neoplasms; Protein Kinases; Proto-Oncogene Proteins c-akt; Resveratrol; Stilbenes; TOR Serine-Threonine Kinases; Tritium | 2007 |
Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Blotting, Western; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lysophospholipids; Mitogen-Activated Protein Kinases; Ovarian Neoplasms; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Ribosomal Protein S6 Kinases, 70-kDa; RNA, Messenger; Stilbenes; Transfection; Vascular Endothelial Growth Factor A | 2007 |